Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 1, 2008, Pages 180-187

  Chen, Yue Feng ^a   Kobayashi, Satoru ^a   Chen, Jinghai ^a   Redetzke, Rebecca A ^a   Said, Suleman ^a   Liang, Qiangrong ^a   Gerdes, A Martin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Akt; Apoptosis; Cardiomyocyte; Myocardial infarction; Thyroid hormone

Indexed keywords

DNA; LIOTHYRONINE; PROTEIN KINASE B; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DNA STRUCTURE; ENZYME PHOSPHORYLATION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART PROTECTION; HORMONE ACTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION; SYSTOLE;

ANIMALS; APOPTOSIS; BODY WEIGHT; DIIODOTHYRONINES; ENZYME ACTIVATION; FEMALE; HEMODYNAMICS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THYROTROPIN; TIME FACTORS; TRIIODOTHYRONINE;

RATTUS;

EID: 37549023861     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.09.009     Document Type: Article

References (41)

1. Sam F., Sawyer D.B., Chang D.L., Eberli F.R., Ngoy S., Jain M., et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279 (2000) H422-H428
2. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280 (2001) H2726-H2731
3. Cheng W., Kajstura J., Nitahara J.A., Li B., Reiss K., Liu Y., et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226 (1996) 316-327
4. Olivetti G., Quaini F., Sala R., Lagrasta C., Corradi D., Bonacina E., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28 (1996) 2005-2016
5. Li Q., Li B., Wang X., Leri A., Jana K.P., Liu Y., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100 (1997) 1991-1999
6. De Marinis L., Mancini A., Masala R., Torlontano M., Sandric S., and Barbarino A. Evaluation of pituitary-thyroid axis response to acute myocardial infarction. J Endocrinol Invest 8 (1985) 507-511
7. Veres I., Pechan J., Murin J., and Ondrejka P. Changes in levels of thyroid hormones and TSH in acute myocardial infarction. Bratisl Lek Listy 93 (1992) 167-174
8. Takada K., Shimai S., Takano T., and Hayakawa H. The prevalence and significance of abnormal thyroid hormone metabolism in acute myocardial infarction. Nippon Ika Daigaku Zasshi 61 (1994) 220-231
9. Eber B., Schumacher M., Langsteger W., Zweiker R., Fruhwald F.M., Pokan R., et al. Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 86 (1995) 152-156
10. Ojamaa K., Kenessey A., Shenoy R., and Klein I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 279 (2000) E1319-E1324
11. Friberg L., Werner S., Eggertsen G., and Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?. Arch Intern Med 162 (2002) 1388-1394
12. Gay R., Gustafson T.A., Goldman S., and Morkin E. Effects of l-thyroxine in rats with chronic heart failure after myocardial infarction. Am J Physiol 253 (1987) H341-H346
13. Kuzman J.A., Gerdes A.M., Kobayashi S., and Liang Q. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. J Mol Cell Cardiol 39 (2005) 841-844
14. Kuzman J.A., Vogelsang K.A., Thomas T.A., and Gerdes A.M. L-thyroxine activates Akt signaling in the heart. J Mol Cell Cardiol 39 (2005) 251-258
15. Selye H., Bajusz E., Grasso S., and Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11 (1960) 398-407
16. Tamura T., Said S., Harris J., Lu W., and Gerdes A.M. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 102 (2000) 253-259
17. Zimmer H.G., Gerdes A.M., Lortet S., and Mall G. Changes in heart function and cardiac cell size in rats with chronic myocardial infarction. J Mol Cell Cardiol 22 (1990) 1231-1243
18. Pfeffer J.M., Pfeffer M.A., and Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57 (1985) 84-95
19. Litwin S.E., Katz S.E., Morgan J.P., and Douglas P.S. Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J Am Coll Cardiol 28 (1996) 773-781
20. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79 (1996) 949-956
21. Pozzi S., Malferrari G., Biunno I., and Samaja M. Low-flow ischemia and hypoxia stimulate apoptosis in perfused hearts independently of reperfusion. Cell Physiol Biochem 12 (2002) 39-46
22. Trivieri M.G., Oudit G.Y., Sah R., Kerfant B.G., Sun H., Gramolini A.O., et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A 103 (2006) 6043-6048
23. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., and Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007) 575-579
24. Robuschi G., Medici D., Fesani F., Barboso G., Montermini M., d'Amato L., et al. Cardiopulmonary bypass: a low T4 and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). Horm Res 23 (1986) 151-158
25. Bettendorf M., Schmidt K.G., Tiefenbacher U., Grulich-Henn J., Heinrich U.E., and Schonberg D.K. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 41 (1997) 375-379
26. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid 7 (1997) 139-145
27. Carrel T., Eckstein F., Englberger L., Mury R., and Mohacsi P. Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature. Eur J Heart Fail 4 (2002) 577-582
28. Jeevanandam V., Todd B., Hellman S., Eldridge C., McClurken J., and Addonizio V.P. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool. Transplant Proc 25 (1993) 3305-3306
29. Rosendale J.D., Kauffman H.M., McBride M.A., Chabalewski F.L., Zaroff J.G., Garrity E.R., et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75 (2003) 1336-1341
30. Jeevanandam V., Todd B., Regillo T., Hellman S., Eldridge C., and McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 13 (1994) 681-687 [discussion 685-687]
31. Novitzky D., Cooper D.K., Chaffin J.S., Greer A.E., DeBault L.E., and Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 49 (1990) 311-316
32. Muller Y., Rocchi E., Lazaro J.B., and Clos J. Thyroid hormone promotes BCL-2 expression and prevents apoptosis of early differentiating cerebellar granule neurons. Int J Dev Neurosci 13 (1995) 871-885
33. Hara M., Suzuki S., Mori J., Yamashita K., Kumagai M., Sakuma T., et al. Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid × receptor-specific ligands. Thyroid 10 (2000) 1023-1034
34. Asahara S., Sato A., Aljonaid A.A., and Maruo T. Thyroid hormone synergizes with follicle stimulating hormone to inhibit apoptosis in porcine granulosa cells selectively from small follicles. Kobe J Med Sci 49 (2003) 107-116
35. Pantos C., Mourouzis I., Xinaris C., Kokkinos A.D., Markakis K., Dimopoulos A., et al. Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling. Eur J Endocrinol 156 (2007) 415-424
36. Matsui T., Nagoshi T., and Rosenzweig A. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2 (2003) 220-223
37. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., and Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37 (2004) 449-471
38. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15 (2001) 2203-2208
39. DeBosch B., Sambandam N., Weinheimer C., Courtois M., and Muslin A.J. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281 (2006) 32841-32851
40. Mahaffey K.W., Raya T.E., Pennock G.D., Morkin E., and Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. Circulation 91 (1995) 794-801
41. Zheng W., Weiss R.M., Wang X., Zhou R., Arlen A.M., Lei L., et al. DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol 286 (2004) H1994-H2000